Atara Biotherapeutics, Inc. (NASDAQ:ATRA)
Atara Biotherapeutics, Inc. has a live Insider Score.
Scored on 1 qualifying trade from 1 insider in the last 90 days.
Loses money on what it sells.
- Revenue
- $6.2M
- Net income
- -$16.7M
- Net margin
- -269.4%
Not enough balance-sheet detail to judge the debt load.
- Total debt
- $9.9M
- Cash
- $3.2M
Comfortably covers what is due within a year.
- Current assets
- $13.5M
- Current liabilities
- $6.8M
- Current ratio
- 1.98
Consumes cash and must keep raising it.
- Operating cash flow
- -$21.9M
- Free cash flow
- -$21.9M
- FCF margin
- -353.5%
Burning cash with under a year of runway — expect a raise.
- Shares outstanding
- 15.0M
- Share growth (1y)
- 23.3%
- Cash runway
- 2 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
ATRA Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 630.00 K | 516.00 K | 1.59 M | 3.45 M | 17.57 M | 98.15 M |
| Revenue Growth (YoY) | -96.42 % | -99.47 % | -95.13 % | -91.41 % | -38.63 % | 258.77 % |
| Cost of Revenue | 191.00 K | 124.00 K | 104.00 K | 115.00 K | 554.00 K | 20.44 M |
| Gross Profit | 439.00 K | 392.00 K | 1.49 M | 3.34 M | 17.02 M | 77.71 M |
| SG&A Expense | 3.81 M | 3.60 M | 4.28 M | 3.99 M | 5.93 M | 11.47 M |
| R&D Expense | 1.34 M | 164.00 K | -223.00 K | 2.92 M | 7.31 M | 27.43 M |
| Operating Expenses | 5.16 M | 3.76 M | 4.05 M | 6.91 M | 13.82 M | 38.91 M |
| Operating Income | -4.72 M | -3.37 M | -2.56 M | -3.57 M | 3.20 M | 38.80 M |
| Pretax Income | -4.83 M | -4.14 M | -3.41 M | -4.28 M | 2.39 M | 38.01 M |
| Tax Provision | 1.00 K | 0.00 | 0.00 | 28.00 K | 3.00 K | 0.00 |
| Net Income | -4.83 M | -4.14 M | -3.41 M | -4.30 M | 2.39 M | 38.01 M |
| EPS (Basic) | -0.32 | -0.29 | -0.25 | -0.32 | 0.20 | 3.53 |
| EPS (Diluted) | -0.32 | -0.29 | -0.25 | -0.32 | 0.19 | 3.50 |
| Shares Outstanding | 15.03 M | 14.08 M | 12.54 M | 13.56 M | 12.20 M | 10.76 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.